(1S,5R,6R,13R,21S)-5,13-bis(3,4-dihydroxyphenyl)-21-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,12,14-trioxapentacyclo[11.7.1.02,11.03,8.015,20]henicosa-2(11),3(8),9,15,17,19-hexaene-6,9,17,19-tetrol

Details

Top
Internal ID 8a993bf9-3622-496f-b596-94ef8f2ed721
Taxonomy Phenylpropanoids and polyketides > Flavonoids > Biflavonoids and polyflavonoids
IUPAC Name (1S,5R,6R,13R,21S)-5,13-bis(3,4-dihydroxyphenyl)-21-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,12,14-trioxapentacyclo[11.7.1.02,11.03,8.015,20]henicosa-2(11),3(8),9,15,17,19-hexaene-6,9,17,19-tetrol
SMILES (Canonical) C1C(C(OC2=C1C(=CC3=C2C4C(C(O3)(OC5=CC(=CC(=C45)O)O)C6=CC(=C(C=C6)O)O)OC7C(C(C(C(O7)CO)O)O)O)O)C8=CC(=C(C=C8)O)O)O
SMILES (Isomeric) C1[C@H]([C@H](OC2=C1C(=CC3=C2[C@H]4[C@@H]([C@@](O3)(OC5=CC(=CC(=C45)O)O)C6=CC(=C(C=C6)O)O)O[C@H]7[C@@H]([C@H]([C@H]([C@H](O7)CO)O)O)O)O)C8=CC(=C(C=C8)O)O)O
InChI InChI=1S/C36H34O17/c37-11-25-29(46)30(47)31(48)35(49-25)51-34-28-26-21(44)7-14(38)8-23(26)52-36(34,13-2-4-17(40)20(43)6-13)53-24-10-18(41)15-9-22(45)32(50-33(15)27(24)28)12-1-3-16(39)19(42)5-12/h1-8,10,22,25,28-32,34-35,37-48H,9,11H2/t22-,25-,28+,29+,30+,31-,32-,34+,35+,36-/m1/s1
InChI Key JUIIUJBWZYKSEP-DXNKJTEVSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C36H34O17
Molecular Weight 738.60 g/mol
Exact Mass 738.17959961 g/mol
Topological Polar Surface Area (TPSA) 289.00 Ų
XlogP 0.80
Atomic LogP (AlogP) 0.62
H-Bond Acceptor 17
H-Bond Donor 12
Rotatable Bonds 5

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1S,5R,6R,13R,21S)-5,13-bis(3,4-dihydroxyphenyl)-21-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,12,14-trioxapentacyclo[11.7.1.02,11.03,8.015,20]henicosa-2(11),3(8),9,15,17,19-hexaene-6,9,17,19-tetrol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption - 0.6717 67.17%
Caco-2 - 0.8971 89.71%
Blood Brain Barrier - 0.5750 57.50%
Human oral bioavailability - 0.8857 88.57%
Subcellular localzation Mitochondria 0.5045 50.45%
OATP2B1 inhibitior - 0.8480 84.80%
OATP1B1 inhibitior + 0.8778 87.78%
OATP1B3 inhibitior + 0.9290 92.90%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 0.7750 77.50%
BSEP inhibitior + 0.8618 86.18%
P-glycoprotein inhibitior + 0.6569 65.69%
P-glycoprotein substrate - 0.6195 61.95%
CYP3A4 substrate + 0.6768 67.68%
CYP2C9 substrate - 0.8002 80.02%
CYP2D6 substrate - 0.7754 77.54%
CYP3A4 inhibition - 0.9314 93.14%
CYP2C9 inhibition - 0.9322 93.22%
CYP2C19 inhibition - 0.8611 86.11%
CYP2D6 inhibition - 0.9200 92.00%
CYP1A2 inhibition - 0.9301 93.01%
CYP2C8 inhibition + 0.7712 77.12%
CYP inhibitory promiscuity - 0.8859 88.59%
UGT catelyzed - 0.6000 60.00%
Carcinogenicity (binary) - 0.9900 99.00%
Carcinogenicity (trinary) Non-required 0.6438 64.38%
Eye corrosion - 0.9934 99.34%
Eye irritation - 0.8918 89.18%
Skin irritation - 0.8032 80.32%
Skin corrosion - 0.9605 96.05%
Ames mutagenesis - 0.5100 51.00%
Human Ether-a-go-go-Related Gene inhibition + 0.9049 90.49%
Micronuclear + 0.6159 61.59%
Hepatotoxicity - 0.8552 85.52%
skin sensitisation - 0.9030 90.30%
Respiratory toxicity + 0.5889 58.89%
Reproductive toxicity + 0.7333 73.33%
Mitochondrial toxicity + 0.5125 51.25%
Nephrotoxicity + 0.6186 61.86%
Acute Oral Toxicity (c) III 0.4801 48.01%
Estrogen receptor binding + 0.8050 80.50%
Androgen receptor binding + 0.7531 75.31%
Thyroid receptor binding + 0.5875 58.75%
Glucocorticoid receptor binding + 0.5488 54.88%
Aromatase binding + 0.6228 62.28%
PPAR gamma + 0.7538 75.38%
Honey bee toxicity - 0.6542 65.42%
Biodegradation - 0.8750 87.50%
Crustacea aquatic toxicity + 0.5100 51.00%
Fish aquatic toxicity + 0.6924 69.24%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.91% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.98% 96.09%
CHEMBL233 P35372 Mu opioid receptor 96.97% 97.93%
CHEMBL3137262 O60341 LSD1/CoREST complex 95.96% 97.09%
CHEMBL2581 P07339 Cathepsin D 94.21% 98.95%
CHEMBL236 P41143 Delta opioid receptor 92.61% 99.35%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 90.71% 94.45%
CHEMBL1951 P21397 Monoamine oxidase A 90.40% 91.49%
CHEMBL1806 P11388 DNA topoisomerase II alpha 88.24% 89.00%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 87.07% 99.15%
CHEMBL5608 Q16288 NT-3 growth factor receptor 86.94% 95.89%
CHEMBL3401 O75469 Pregnane X receptor 86.25% 94.73%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 85.49% 85.14%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 85.00% 95.56%
CHEMBL1293249 Q13887 Kruppel-like factor 5 84.59% 86.33%
CHEMBL4208 P20618 Proteasome component C5 83.36% 90.00%
CHEMBL5339 Q5NUL3 G-protein coupled receptor 120 82.77% 95.78%
CHEMBL3714130 P46095 G-protein coupled receptor 6 81.37% 97.36%
CHEMBL3476 O15111 Inhibitor of nuclear factor kappa B kinase alpha subunit 81.16% 95.83%

Cross-Links

Top
PubChem 118731401
NPASS NPC185231